Frequency Therapeutics Stock Fundamentals
| KRRO Stock | 52.31 1.69 3.34% |
Frequency Therapeutics fundamentals help investors to digest information that contributes to Frequency Therapeutics' financial success or failures. It also enables traders to predict the movement of Frequency Stock. The fundamental analysis module provides a way to measure Frequency Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Frequency Therapeutics stock.
As of the 25th of November 2024, Cost Of Revenue is likely to grow to about 4.6 M, while Depreciation And Amortization is likely to drop about 2.1 M. Frequency | Select Account or Indicator |
Frequency Therapeutics Company Return On Asset Analysis
Frequency Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Frequency Therapeutics Return On Asset | -0.35 |
Most of Frequency Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Frequency Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Frequency Total Assets
Total Assets |
|
Based on the latest financial disclosure, Frequency Therapeutics has a Return On Asset of -0.3527. This is 95.97% lower than that of the Biotechnology sector and 98.51% lower than that of the Health Care industry. The return on asset for all United States stocks is 151.93% higher than that of the company.
Frequency Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Frequency Therapeutics's current stock value. Our valuation model uses many indicators to compare Frequency Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Frequency Therapeutics competition to find correlations between indicators driving Frequency Therapeutics's intrinsic value. More Info.Frequency Therapeutics is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . At this time, Frequency Therapeutics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Frequency Therapeutics' earnings, one of the primary drivers of an investment's value.Frequency Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Frequency Therapeutics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Frequency Therapeutics could also be used in its relative valuation, which is a method of valuing Frequency Therapeutics by comparing valuation metrics of similar companies.Frequency Therapeutics is currently under evaluation in return on asset category among its peers.
Frequency Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Frequency Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Frequency Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Frequency Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 394.84 M | ||||
| Shares Outstanding | 9.37 M | ||||
| Shares Owned By Insiders | 6.44 % | ||||
| Shares Owned By Institutions | 91.37 % | ||||
| Number Of Shares Shorted | 261.96 K | ||||
| Price To Book | 2.73 X | ||||
| EBITDA | (80.9 M) | ||||
| Net Income | (81.17 M) | ||||
| Total Debt | 33.21 M | ||||
| Book Value Per Share | 19.28 X | ||||
| Cash Flow From Operations | (67.28 M) | ||||
| Short Ratio | 1.57 X | ||||
| Earnings Per Share | (9.42) X | ||||
| Target Price | 137.76 | ||||
| Number Of Employees | 101 | ||||
| Market Capitalization | 490.05 M | ||||
| Total Asset | 221.66 M | ||||
| Retained Earnings | (183 M) | ||||
| Working Capital | 153.25 M | ||||
| Net Asset | 221.66 M |
About Frequency Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Frequency Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Frequency Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Frequency Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 9.4 M | 11.5 M | |
| Cost Of Revenue | 3.6 M | 4.6 M | |
| Stock Based Compensation To Revenue | 0.05 | 0.05 | |
| Sales General And Administrative To Revenue | 0.75 | 0.66 | |
| Research And Ddevelopement To Revenue | 1.52 | 0.89 | |
| Capex To Revenue | 0.28 | 0.14 | |
| Revenue Per Share | 3.64 | 3.46 | |
| Ebit Per Revenue | (2.90) | (3.05) |
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Frequency Stock
| 0.67 | MTEM | Molecular Templates | PairCorr |
| 0.58 | ME | 23Andme Holding | PairCorr |
| 0.57 | TPST | Tempest Therapeutics | PairCorr |
| 0.53 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.5 | A | Agilent Technologies Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Frequency Therapeutics Piotroski F Score and Frequency Therapeutics Altman Z Score analysis. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.42) | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.